These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6380063)

  • 1. Lymphocyte monitoring in renal transplantation.
    Burton RC
    Transplant Proc; 1984 Aug; 16(4):983-7. PubMed ID: 6380063
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and therapeutic applications of monoclonal antibodies to human T-cell subsets in renal transplant recipients.
    Cosimi AB
    Urol Clin North Am; 1983 May; 10(2):289-99. PubMed ID: 6344388
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization and alterations of lymphocyte subpopulations in renal allograft recipients.
    Chatterjee SN; Gershwin ME; Eckles D
    Transplant Proc; 1979 Mar; 11(1):374-8. PubMed ID: 377659
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.
    Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lower RR; Lee HM; Mohanakumar T
    Transplantation; 1982 Mar; 33(3):317-9. PubMed ID: 6461117
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological monitoring after renal transplantation from living donors].
    Laurentaci G; Favoino B; Selvaggi FP
    Minerva Chir; 1980 May; 35(10):751-60. PubMed ID: 7005731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation with clinical types and lymphocyte subsets in chronic renal allograft rejection.
    Tanabe K; Toma H; Takahashi K; Teraoka S; Ota K
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1285-91. PubMed ID: 3546879
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal anti-T12 antibody as therapy for renal allograft rejection.
    Carpenter CB; Milford EL; Reinherz EL; Schlossman SF; Tilney NL; Strom TB; Kirkman RL; Busch GJ; Araujo JL
    Trans Assoc Am Physicians; 1983; 96():84-92. PubMed ID: 6388105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMA 031 effectively reverses steroid-resistant rejection in renal transplants.
    Pfeffer PF; Jakobsen A; Albrechtsen D; Sødal G; Brekke I; Bentdal O; Leivestad T; Fauchald P; Flatmark A
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1099-100. PubMed ID: 1989159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring immunosuppression following renal transplantation.
    Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
    Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic monitoring of renal transplants by subpopulations of T and B cells.
    Tan M; Nishihira T; Taguchi Y; Tsutsumi E; Kasai M
    Transplant Proc; 1979 Jun; 11(2):1237-8. PubMed ID: 382497
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression.
    Carpenter CB
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2770-3. PubMed ID: 3547954
    [No Abstract]   [Full Text] [Related]  

  • 15. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection.
    Battochio A; Solez K; Poppema S; Cockfield S; Rayner D
    Transplant Proc; 1996 Feb; 28(1):482-3. PubMed ID: 8644320
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoid inhibitory action on OKT3-stimulated peripheral blood lymphocytes from renal transplant patients.
    Musiani P; Citterio F; Maggiano N; Pozzetto U; Lauriola L; Ranelletti FO; Aiello FB; Piantelli M
    Transplantation; 1984 Sep; 38(3):309-12. PubMed ID: 6382720
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplant monitoring with monoclonal antibodies to human T cell subsets by 51Cr release in complement-dependent cytotoxicity (CDC-Cr): a preliminary study.
    Kovithavongs T; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1093-6. PubMed ID: 6380056
    [No Abstract]   [Full Text] [Related]  

  • 18. T-cell subsets in a cyclosporin-A treated recipient of cadaveric kidney allograft as defined by theophylline sensitivity and monoclonal antibodies.
    Shohat B; Shapira Z; Servadio C
    Dev Biol Stand; 1984; 57():361-6. PubMed ID: 6396131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute renal insufficiency and rejection of transplanted kidneys].
    Kreis H
    Nouv Presse Med; 1979 Oct; 8(37):2943-5. PubMed ID: 388342
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.